Celyad – Treating Acute Myeloid Leukemia and MM + 5 Solid Tumors With Stem Cells
Finding Genius Podcast
Richard Jacobs
4.4 • 1K Ratings
🗓️ 6 March 2017
⏱️ 34 minutes
🧾️ Download transcript
Summary
Georges Rawadi, VP business development talks to us about the latest in stem cell technology and how Celyad is revolutionizing the battle against cancer.
Georges shares how Celyad is working on battling cancer through stem cell technology. Specifically, AML (Acute Myeloid Leukemia) and MM + 5 solid tumors, the forms that are life threatening, with a handful of treatments.
With the current technology being limited and the government regulations being a barrier because of the years necessary for Stage 1 2 and 3 of clinical trials, commercializing these therapies takes years. So make sure you remain tuned to the podcast to be updated. Don’t forget to listen, share and subscribe to the podcast.
Transcript
Click on a timestamp to play from that location
| 0:00.0 | Welcome to Almost Here, Around the Corner of Future Technology Podcasts with Richard Jacobs. |
| 0:07.0 | Future Technologies is poised to transform our lives for better or worse for the focus of this podcast. Almost here |
| 0:14.3 | means these technologies are now here and starting to be used. We're just around the |
| 0:18.8 | corner from Bitcoin to Artificial Intelligence, 3D printing, blockchain, virtual reality, and more. |
| 0:25.4 | Hi this is Richard Jacobs with Future Tech Podcast almost here around the corner |
| 0:31.4 | technologies. Today I have an interesting guest Georgis Rawati, |
| 0:35.8 | VP of Business Development and Intellectual Property at Selyad, |
| 0:40.6 | C-E-L-Y-A-D.com. Georgis, how you doing? GED. |
| 0:43.0 | com. Georgis how you doing? |
| 0:45.0 | Hi how are you? I'm doing fine. |
| 0:48.0 | Thank you for coming sir. |
| 0:50.0 | You welcome my pleasure. |
| 0:52.0 | Yeah, can you give listeners an overview of what |
| 0:57.2 | Celiaad does with stem cell technology? Yes, well I mean a Cel, it's a cell therapy company where our mission is to develop a breakthrough technology for life-threatening disease. |
| 1:15.0 | And since our inception back in 2007, |
| 1:19.7 | we have been developing cell therapy initially for cardiovascular diseases and |
| 1:24.8 | since more than two years we are also active in the cell-based immunotherapy for |
| 1:32.4 | cancer. |
| 1:36.0 | Definitely, we are using different sources of cells, |
| 1:40.8 | not only stem cell, but also T cell which are primary T cell from patients and we today |
| 1:50.3 | are in clinical stage phase, phase one, phase two, and phase three |
| 1:55.2 | to make the development. |
... |
Please login to see the full transcript.
Disclaimer: The podcast and artwork embedded on this page are from Richard Jacobs, and are the property of its owner and not affiliated with or endorsed by Tapesearch.
Generated transcripts are the property of Richard Jacobs and are distributed freely under the Fair Use doctrine. Transcripts generated by Tapesearch are not guaranteed to be accurate.
Copyright © Tapesearch 2026.

